Congenital disorder of deglycosylation

Congenital disorder of deglycosylation results from deficiencies in the NGLY1 gene.  NGLY1 encodes the enzyme N-glycanase 1, which functions to removes glycosyl groups (sugars) from misfolded proteins. Deglycosylation of misfolded proteins is one of the first steps in their degradation and in the absence of NGLY1 function, these proteins accumulate and are thought to form aggregates that may damage cells.  Patients display symptoms that include delayed speech and development of motor skills, movement abnormalities and seizures, liver issues, neurodegeneration of eye nerves and reductions in, or absence of, tears.

For additional information see:


Stocks for studying Congenital disorder of deglycosylation
Relevant gene in stockFly disease model or related mutation or transgeneStk #Comments
PnglTI{TI}Pngl[PL]81106A stop codon and mini-w[+] were introduced into the third coding exon of Pngl via CRISPR-Cas9 resulting in expression of a protein truncated at amino acid 420.
PnglP{TRiP.HMS02424}attP4042592Expresses dsRNA for RNAi of Pngl (FBgn0033050) under UAS control in the VALIUM20 vector.
PnglP{TRiP.HMJ21590}attP4054853Expresses dsRNA for RNAi of Pngl (FBgn0033050) under UAS control in the VALIUM20 vector.
PnglTI{KozakGAL4}Pngl[CR70053-KO-kG4]94958CRISPR-based insertion of a CRIMIC cassette results in expression of GAL4 under Pngl control and deletion of some or most of Pngl coding sequence.
PnglP{TKO-UAS.GS06195}attP40602388Expresses sgRNA under the control of UAS for Cas9-mediated mutagenesis of Pngl (FBgn0033050).
PnglP{EPgy2}Pngl[EY05022]19848This P{EPgy2} insertion in Pngl 5' UTR is uncharacterized but is in the right orientation to overexpress Pngl in the presence of GAL4.
items per page